振德醫療(603301.SH)預計2020年度淨利潤同比增加23.83億-24.61億元
格隆匯 1 月 14日丨振德醫療(603301.SH)公佈,經財務部門初步測算,公司預計2020年度實現歸屬於上市公司股東的淨利潤與上年同期(法定披露數據)15689萬元相比,增加23.83億元到24.61億元。
公司預計2020年度實現歸屬於上市公司股東的扣除非經常性損益的淨利潤與上年同期(法定披露數據)1.06億元相比,增加24.07億元到24.59億元。
公司2020年度預計實現營業收入102.67億元到106.65億元,較上年同期增加83.99億元到87.97億元,增長主要原因為:
(1)受疫情影響公司防疫類防護用品(主要為口罩、防護服、隔離衣產品)銷售大幅度增加,2020年度防疫類防護用品實現銷售75.56億元到77.46億元,較上年同期增加74.77億元到76.67億元。
(2)受益公司多年來建立的國內市場醫院線、零售線(包括藥店零售線、電商線等)全渠道優勢和國際客户良好的業務合作體系,結合公司利用在本次疫情期間公司良好的供應能力表現、健康有序的價格管理體系獲得的良好行業口碑和2019年收購英國Rocialle Healthcare Limited公司55%股權納入公司合併報表範圍,公司銷售渠道在報吿期內得到了快速擴張,進一步提高了整體市場佔有率和覆蓋率,公司2020年度實現剔除防疫類防護用品後的銷售收入27.11億元到29.19億元,較上年同期增加9.23億元到11.31億元,同比增長52%到63%。
公司2020年度業務規模大幅增長帶來的規模化生產經營優勢、公司供應鏈能力和經營管理能力的不斷優化,促使報吿期內公司產品整體毛利率提升。
受上述因素綜合影響,公司2020年度經營業績實現大幅度增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.